This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Acadia Healthcare (ACHC) Tops Q2 Earnings, Revises View
by Zacks Equity Research
Acadia Healthcare's (ACHC) second-quarter results were boosted by significant revenue growth.
Top Ranked Growth Stocks to Buy for July 28th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 28th:
Anthem (ANTM) Beats Q2 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Anthem's (ANTM) strong second-quarter results were mainly driven by significant rise in medical enrollment, which aided revenue growth.
Universal Health (UHS) Q2 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Universal Health's (UHS) lagged second-quarter earnings primarily due to lower revenues and higher expenses.
New Strong Buy Stocks for July 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Centene's (CNC) Q2 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Centene beats on earnings. Our consensus called for EPS of $1.30, and the company reported adjusted diluted EPS of $1.59.
Centene (CNC) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Centene's (CNC) second-quarter earnings are likely to be driven by Health Net buyout. However, surging level of SG&A expenses might put pressure on the bottom line.
Centene & Unit Inks New Deal to Expand Foothold in Ferguson
by Zacks Equity Research
Centene & its subsidiary, Home State Health entered into an agreement with Schnuck Markets and the Betty Jean Kerr People's Health Centers to boost Foothold in Ferguson
Is Centene Corp (CNC) a Great Stock for Value Investors?
by Zacks Equity Research
Is Centene Corp. a great pick from the value investor's perspective right now? Read on to know more.
Will Health Insurers Have to Rework Under ACHA?
by Zacks Equity Research
The overall expectation is that the new regulatory framework will provide for a relatively lighter regulatory touch and will be friendlier to the industry. That said, the expected change would have some negative effects on the industry as well.
Why Is Centene (CNC) Up 2.7% Since the Last Earnings Report?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Ranked Growth Stocks to Buy for May 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, May 9th:
5 Healthcare Innovators I'm Still Buying
by Kevin Cook
When you think long-term about the megatrends in healthcare, it makes picking winners easier
Humana (HUM) Beats on Earnings, Misses Revenues in Q1
by Zacks Equity Research
Humana Inc.'s (HUM) first-quarter 2017 operating earnings per share of $2.75 beat the Zacks Consensus Estimate by approximately 8%.
Top Ranked Growth Stocks to Buy for May 3rd
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, May 3rd:
Aetna (AET) Earnings Beat, Revenues Miss Estimates in Q1
by Zacks Equity Research
Health insurer Aetna Inc.'s (AET) first-quarter 2017 earnings of $2.71 per share surpassed the Zacks Consensus Estimate of $2.36 and also grew 17% year over year.
Tenet Healthcare (THC) Q1 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Tenet Healthcare Corp. (THC) reported first-quarter 2017 operating earnings of 27 cents per share that missed the Zacks Consensus Estimate of 53 cents by 79%.
Community Health Systems (CYH) Q1 Earnings Beat Estimates
by Zacks Equity Research
Community Health Systems, Inc. (CYH) reported adjusted earnings of 8 cents per share in the first quarter of 2017, which beat the Zacks Consensus Estimate of 6 cents by 33%.
Universal Health (UHS) Beats on Q1 Earnings, Misses Revenues
by Zacks Equity Research
Universal Health Services Inc. (UHS) reported first-quarter 2017 adjusted earnings of $2.10 per share that surpassed the Zacks Consensus Estimate by 1.9%.
Anthem's (ANTM) Beats Q1 Earnings on Increased Revenues
by Zacks Equity Research
Anthem Inc.'s (ANTM) first-quarter 2017 adjusted net income per share of $4.7 surpassed the Zacks Consensus Estimate of $3.8 by 23.7%.
Centene's (CNC) Q1 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Centene beats on earnings as the consensus called for EPS of $1.06, and the company reported adjusted diluted EPS of $1.12.
Healthcare Earnings to Watch on Apr 25: ACHC, CNC & UHS
by Zacks Equity Research
The Healthcare sector has been in limelight since the change of power at the White House.
Hospital Stocks Soar Upon the Death of TrumpCare
by Joseph Lu
While the Republican's unsuccessful attempt to repeal and replace the Affordable Care Act (ACA) was a disaster for the GOP, it was great news for hospital stocks like HCA Holdings (HCA) and Universal Health Service Inc. (UHS)
Zacks Industry Outlook Highlights: Molina Healthcare, Centene, WellCare Health Plans and UnitedHealth Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Molina Healthcare, Centene, WellCare Health Plans and UnitedHealth Group
Centene (CNC) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
Centene Corporation (CNC) saw its shares rise above 5% in the last trading session.